JP2012517593A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012517593A5 JP2012517593A5 JP2011549276A JP2011549276A JP2012517593A5 JP 2012517593 A5 JP2012517593 A5 JP 2012517593A5 JP 2011549276 A JP2011549276 A JP 2011549276A JP 2011549276 A JP2011549276 A JP 2011549276A JP 2012517593 A5 JP2012517593 A5 JP 2012517593A5
- Authority
- JP
- Japan
- Prior art keywords
- measured concentration
- future
- subject
- renal
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003907 kidney function Effects 0.000 claims 34
- 201000011040 acute kidney failure Diseases 0.000 claims 24
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 19
- 208000033626 Renal failure acute Diseases 0.000 claims 19
- 238000000034 method Methods 0.000 claims 16
- 208000012998 acute renal failure Diseases 0.000 claims 14
- 238000003556 assay Methods 0.000 claims 14
- 230000006378 damage Effects 0.000 claims 12
- 208000020832 chronic kidney disease Diseases 0.000 claims 10
- 230000007423 decrease Effects 0.000 claims 9
- 210000003734 kidney Anatomy 0.000 claims 9
- 206010019280 Heart failures Diseases 0.000 claims 6
- 238000012959 renal replacement therapy Methods 0.000 claims 6
- 102000030914 Fatty Acid-Binding Human genes 0.000 claims 5
- 108090000569 Fibroblast Growth Factor-23 Proteins 0.000 claims 5
- 102000004042 Fibroblast Growth Factor-23 Human genes 0.000 claims 5
- 102000013462 Interleukin-12 Human genes 0.000 claims 5
- 108010065805 Interleukin-12 Proteins 0.000 claims 5
- 208000006011 Stroke Diseases 0.000 claims 5
- 102100029477 Vitamin K-dependent protein C Human genes 0.000 claims 5
- 101710193900 Vitamin K-dependent protein C Proteins 0.000 claims 5
- 230000000844 anti-bacterial effect Effects 0.000 claims 5
- 239000007795 chemical reaction product Substances 0.000 claims 5
- 208000028208 end stage renal disease Diseases 0.000 claims 5
- 201000000523 end stage renal failure Diseases 0.000 claims 5
- 230000002708 enhancing effect Effects 0.000 claims 5
- 108091022862 fatty acid binding Proteins 0.000 claims 5
- 230000036252 glycation Effects 0.000 claims 5
- 229940117681 interleukin-12 Drugs 0.000 claims 5
- 208000010125 myocardial infarction Diseases 0.000 claims 5
- 230000035699 permeability Effects 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 210000001124 body fluid Anatomy 0.000 claims 4
- 239000010839 body fluid Substances 0.000 claims 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- 206010061481 Renal injury Diseases 0.000 claims 3
- 231100000637 nephrotoxin Toxicity 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 230000001154 acute effect Effects 0.000 claims 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 208000037806 kidney injury Diseases 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 230000003589 nefrotoxic effect Effects 0.000 claims 2
- 231100000381 nephrotoxic Toxicity 0.000 claims 2
- 238000013517 stratification Methods 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 1
- 108010036949 Cyclosporine Proteins 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 102000036675 Myoglobin Human genes 0.000 claims 1
- 108010062374 Myoglobin Proteins 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 claims 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 claims 1
- 229960001265 ciclosporin Drugs 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 229940109239 creatinine Drugs 0.000 claims 1
- 229930182912 cyclosporin Natural products 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000002296 eclampsia Diseases 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 230000024924 glomerular filtration Effects 0.000 claims 1
- 229910001385 heavy metal Inorganic materials 0.000 claims 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 1
- 229960001101 ifosfamide Drugs 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 201000011461 pre-eclampsia Diseases 0.000 claims 1
- 201000001474 proteinuria Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 claims 1
- 229960001052 streptozocin Drugs 0.000 claims 1
- 229960001967 tacrolimus Drugs 0.000 claims 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 238000007631 vascular surgery Methods 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15039709P | 2009-02-06 | 2009-02-06 | |
| US15037609P | 2009-02-06 | 2009-02-06 | |
| US61/150,397 | 2009-02-06 | ||
| US61/150,376 | 2009-02-06 | ||
| US16240409P | 2009-03-23 | 2009-03-23 | |
| US16240109P | 2009-03-23 | 2009-03-23 | |
| US16241009P | 2009-03-23 | 2009-03-23 | |
| US61/162,410 | 2009-03-23 | ||
| US61/162,404 | 2009-03-23 | ||
| US61/162,401 | 2009-03-23 | ||
| US16633709P | 2009-04-03 | 2009-04-03 | |
| US61/166,337 | 2009-04-03 | ||
| PCT/US2010/023294 WO2010091233A1 (en) | 2009-02-06 | 2010-02-05 | Diagnosis and prognosis of renal injury and renal failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015021970A Division JP2015111141A (ja) | 2009-02-06 | 2015-02-06 | 腎損傷および腎不全の診断および予後診断 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012517593A JP2012517593A (ja) | 2012-08-02 |
| JP2012517593A5 true JP2012517593A5 (enExample) | 2013-03-28 |
| JP5981144B2 JP5981144B2 (ja) | 2016-08-31 |
Family
ID=42542389
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011549276A Expired - Fee Related JP5981144B2 (ja) | 2009-02-06 | 2010-02-05 | 腎損傷および腎不全の診断および予後診断 |
| JP2015021970A Pending JP2015111141A (ja) | 2009-02-06 | 2015-02-06 | 腎損傷および腎不全の診断および予後診断 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015021970A Pending JP2015111141A (ja) | 2009-02-06 | 2015-02-06 | 腎損傷および腎不全の診断および予後診断 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120052512A1 (enExample) |
| EP (2) | EP2393934A4 (enExample) |
| JP (2) | JP5981144B2 (enExample) |
| CN (2) | CN102597258B (enExample) |
| AU (1) | AU2010210537B2 (enExample) |
| CA (1) | CA2751430A1 (enExample) |
| HK (1) | HK1220764A1 (enExample) |
| NZ (1) | NZ594772A (enExample) |
| WO (1) | WO2010091233A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2625524A4 (en) * | 2010-10-07 | 2014-05-07 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency |
| TW201250248A (en) * | 2011-04-25 | 2012-12-16 | Kyowa Medex Co Ltd | Prognostication method of renal failure |
| CN103264492B (zh) * | 2013-06-04 | 2015-08-19 | 浙江大学 | 差动传动的微型注塑机的注射装置及方法 |
| CN104569417B (zh) * | 2013-10-12 | 2016-06-01 | 广州瑞博奥生物科技有限公司 | 一种用于早期诊断急性肾损伤的抗体芯片试剂盒 |
| CN104502596A (zh) * | 2014-12-23 | 2015-04-08 | 温州医科大学 | 一种慢性肾病诊断试剂盒 |
| CL2015003047A1 (es) | 2015-10-15 | 2016-06-17 | Univ Chile | Método ex vivo para detectar precozmente injuria renal aguda en pacientes críticos, que comprende la mediciom en una muestra de tres proteinas como biomarcadores, factor de crecimiento fibroblástico 23, klotho y eritropoyetina |
| CA3092472A1 (en) * | 2018-03-02 | 2019-09-06 | Evonik Operations Gmbh | In vitro method for detecting intestinal barrier failure in animals |
| CN111060607B (zh) * | 2019-11-11 | 2021-08-31 | 浙江大学 | 一种用于心脏死亡后捐献供体术前预警移植肾延迟复功的代谢物组合及其筛选方法 |
| CN110878349A (zh) * | 2019-12-06 | 2020-03-13 | 深圳谱元科技有限公司 | 终末期肾病生物标志物及其应用 |
| CN113552369B (zh) * | 2021-07-23 | 2023-10-20 | 江苏省中医院 | 蛋白标志物联合用于2型糖尿病、2型糖尿病肾病的诊断的用途 |
| CN114773629B (zh) * | 2022-05-20 | 2024-04-12 | 昆明理工大学 | 用于创伤性脑损伤的可注射光固化止血水凝胶的制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US6759203B1 (en) * | 1993-09-22 | 2004-07-06 | Xoma Corporation | Method for quantifying BPI in body fluids |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| CA2596469A1 (en) * | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of H Ealth & Human Services | Biomarkers for tissue status |
| US7833732B2 (en) * | 2005-07-21 | 2010-11-16 | The John Hopkins University | Acute renal injury |
| TW200726845A (en) * | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
| US7662578B2 (en) * | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
| EP2064553B2 (en) * | 2006-08-07 | 2023-06-07 | Antibodyshop A/S | Diagnostic test to exclude significant renal injury |
| EP2095107B1 (en) * | 2006-11-14 | 2014-07-02 | Alere San Diego, Inc. | Methods for risk assignment |
| EP2468888B1 (en) * | 2007-01-22 | 2018-04-11 | Medizinische Universität Innsbruck | Novel markers for chronic kidney disease |
| JP5661457B2 (ja) * | 2007-06-06 | 2015-01-28 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | 腎疾患の予測診断 |
-
2010
- 2010-02-05 CN CN201080013530.XA patent/CN102597258B/zh not_active Expired - Fee Related
- 2010-02-05 US US13/148,030 patent/US20120052512A1/en not_active Abandoned
- 2010-02-05 WO PCT/US2010/023294 patent/WO2010091233A1/en not_active Ceased
- 2010-02-05 NZ NZ594772A patent/NZ594772A/xx not_active IP Right Cessation
- 2010-02-05 EP EP10739152A patent/EP2393934A4/en not_active Withdrawn
- 2010-02-05 CA CA2751430A patent/CA2751430A1/en not_active Abandoned
- 2010-02-05 CN CN201610048281.7A patent/CN105675881A/zh active Pending
- 2010-02-05 JP JP2011549276A patent/JP5981144B2/ja not_active Expired - Fee Related
- 2010-02-05 AU AU2010210537A patent/AU2010210537B2/en not_active Ceased
- 2010-02-05 EP EP17171702.8A patent/EP3244213A1/en not_active Withdrawn
-
2015
- 2015-02-06 JP JP2015021970A patent/JP2015111141A/ja active Pending
-
2016
- 2016-07-21 HK HK16108751.4A patent/HK1220764A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012517593A5 (enExample) | ||
| JP2012517592A5 (enExample) | ||
| JP2013519095A5 (enExample) | ||
| JP2013539030A5 (enExample) | ||
| JP2013501920A5 (enExample) | ||
| JP2014529073A5 (enExample) | ||
| JP2013510321A5 (enExample) | ||
| JP2013510322A5 (enExample) | ||
| HRP20160733T1 (hr) | Postupci i pripravci za postavljanje dijagnoze i prognoze ozljede bubrega i bubrežne insuficijencije | |
| JP2017533427A5 (enExample) | ||
| JP2013539861A5 (enExample) | ||
| JP2013515243A5 (enExample) | ||
| Rosolowsky et al. | Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy | |
| JP2021039112A5 (enExample) | ||
| JP2015129764A5 (enExample) | ||
| Crosina et al. | Improving the prediction of cardiac surgery–associated acute kidney injury | |
| JP2013519866A5 (enExample) | ||
| JP2017534874A5 (enExample) | ||
| Delcroix et al. | NGAL usefulness in the intensive care unit three hours after cardiac surgery | |
| Tobe et al. | Impact of albuminuria on the prognosis after transcatheter aortic valve implantation | |
| Miyazaki et al. | Characterization of urate metabolism and complications of patients with renal hypouricemia | |
| Berezin et al. | Utility of irisin and apelin in prediction of heart failure phenotypes in type 2 diabetes mellitus patients | |
| Wouda et al. | FP158 EFFICACY OF THE ANGIOTENSIN RECEPTOR BLOCKER LOSARTAN DURING HIGH POTASSIUM INTAKE IN CKD PATIENTS | |
| JP6312287B2 (ja) | 急性腎障害の予後予測方法 | |
| Albayati et al. | Study Some Haematological And Biochemical Parameters in Patients with Renal Failure in Diyala Province. |